RankingsPricing
  1. US-listed companies
  2. EKSO BIONICS HOLDINGS, INC.

EKSO BIONICS HOLDINGS, INC.EKSO

Market cap
$21.48M
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Mar 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023
Cash and restricted cash29,175252017288111340-9
Cash and restricted cash------11134021-
Accounts receivable, net of allowances of $79 and $40, respectively-2223453556
Accounts receivable, net of allowances of $40 and $28, respectively-2223453556
Inventories-1123322255
Inventories-1123322255
Prepaid expenses and other current assets-0011000011
Prepaid expenses and other current assets-0011000011
Total current assets-29252135151918483120
Total current assets-29252135151918483120
Property and equipment, net-2322221132
Right-of-use assets------11011
Intangible assets, net---------55
Goodwill--00000--00
Other assets-0000000000
Total assets29,17533322438182221494129
Accounts payable-1322322332
Accounts payable-1322322332
Accrued liabilities4,8002244421223
Accrued liabilities4,8002244421223
Deferred revenues, current-------1112
Deferred revenues, current-------1112
Notes payable, current-0--222--21
Notes payable, current-0--222--21
Lease liabilities, current------01000
Lease liabilities, current------01000
Total current liabilities-79691085798
Total current liabilities-79691085798
Deferred revenues-------2112
Notes payable, net-0-75303245
Lease liabilities------10-11
Warrant liabilities----------0
Other non-current liabilities--000000000
Total liabilities14,12411231817151516121516
Convertible preferred stock, $0.001 par value; 10,000 shares authorized; no shares issued and outstanding as of December 31, 2023 and 2022-----------
Convertible preferred stock, $0.001 par value; 10,000 shares authorized; no shares issued and outstanding at December 31, 2022 and 2021-----------
Common stock, $0.001 par value; 141,429 shares authorized; 14,848 and 13,203 shares issued and outstanding as of December 31, 2023 and 2022, respectively6,3500000000000
Common stock, $0.001 par value; 141,429 shares authorized; 13,203 and 12,693 shares issued and outstanding at December 31, 2022 and 2021, respectively6,3500000000000
Additional paid-in capital-94100121166174190204246249252
Additional paid-in capital-94100121166174190204246249252
Accumulated other comprehensive income---0-0-00-1-010
Accumulated other comprehensive income---0-0-00-1-010
Accumulated deficit-16,949-72-91-115-144-171-183-199-209-224-239
Accumulated deficit-16,949-72-91-115-144-171-183-199-209-224-239
Total stockholders' equity15,051239721374372513
Total stockholders' equity15,051239721374372513
Total liabilities and stockholders' equity29,17533322438182221494129
Cash and restricted cash29,175252017288111340-9
Cash and restricted cash------11134021-
Accounts receivable, net of allowances of $79 and $40, respectively-2223453556
Accounts receivable, net of allowances of $40 and $28, respectively-2223453556
Inventories-1123322255
Inventories-1123322255
Prepaid expenses and other current assets-0011000011
Prepaid expenses and other current assets-0011000011
Total current assets-29252135151918483120
Total current assets-29252135151918483120
Property and equipment, net-2322221132
Right-of-use assets------11011
Intangible assets, net---------55
Goodwill--00000--00
Other assets-0000000000
Total assets29,17533322438182221494129
Property and equipment, net-2322221132
Right-of-use assets------11011
Intangible assets, net---------55
Goodwill--00000--00
Other assets-0000000000
Total assets29,17533322438182221494129
Accounts payable-1322322332
Accounts payable-1322322332
Accrued liabilities4,8002244421223
Accrued liabilities4,8002244421223
Deferred revenues, current-------1112
Deferred revenues, current-------1112
Notes payable, current-0--222--21
Notes payable, current-0--222--21
Lease liabilities, current------01000
Lease liabilities, current------01000
Total current liabilities-79691085798
Total current liabilities-79691085798
Deferred revenues-------2112
Notes payable, net-0-75303245
Lease liabilities------10-11
Warrant liabilities----------0
Other non-current liabilities--000000000
Total liabilities14,12411231817151516121516
Deferred revenues-------2112
Notes payable, net-0-75303245
Lease liabilities------10-11
Warrant liabilities--94214620-
Other non-current liabilities--000000000
Total liabilities14,12411231817151516121516
Convertible preferred stock, $0.001 par value; 10,000 shares authorized; no shares issued and outstanding as of December 31, 2023 and 2022-----------
Convertible preferred stock, $0.001 par value; 10,000 shares authorized; no shares issued and outstanding at December 31, 2022 and 2021-----------
Common stock, $0.001 par value; 141,429 shares authorized; 14,848 and 13,203 shares issued and outstanding as of December 31, 2023 and 2022, respectively6,3500000000000
Common stock, $0.001 par value; 141,429 shares authorized; 13,203 and 12,693 shares issued and outstanding at December 31, 2022 and 2021, respectively6,3500000000000
Additional paid-in capital-94100121166174190204246249252
Additional paid-in capital-94100121166174190204246249252
Accumulated other comprehensive income---0-0-00-1-010
Accumulated other comprehensive income---0-0-00-1-010
Accumulated deficit-16,949-72-91-115-144-171-183-199-209-224-239
Accumulated deficit-16,949-72-91-115-144-171-183-199-209-224-239
Total stockholders' equity15,051239721374372513
Total stockholders' equity15,051239721374372513
Total liabilities and stockholders' equity29,17533322438182221494129
Total liabilities and stockholders' equity29,17533322438182221494129